Adolescents and young adults should be included in clinical trials

the ONA take:

A study from the National Cancer Research Institute (NCRI) reports that age limits on clinical trials need to be more flexible to allow access to new treatments for teenage and young adult patients with cancer. The study was funded by NCRI and the Teenage Cancer Trust. It found that broader age limits in clinical trials resulted in more teenagers and young adults participating in clinical trials. As a result, the number of younger patients participating in clinical trials between 2005 and 2010 increased by 13% for those age 15 to 19 years, 5% for those age 20 to 24 years, and 6% for those younger than 14 years. In light of this study, Cancer Research UK has started asking researchers to justify age restrictions on new studies in an effort to recruit more teenage patients with cancer onto its trials.

Adolescents and young adults should be included in clinical trials
Adolescents and young adults should be included in clinical trials
Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology today.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs